Detected ·
Dren Bio
$350M—
Biotechnology company Dren Bio has raised $350M in an oversubscribed private financing round, co-led by Juvia Group and Lightspeed Venture Partners, to advance its antibody-based therapies for cancer and autoimmune diseases.
- Website
- —
- linkedin.com/company/69127740
- Amount
- $350 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-05 16:05:49 UTC
- Signal ID
- a0e3e3f0-d96b-44ee-981c-e9d8cc94638b
As the API returns it
{
"id": "a0e3e3f0-d96b-44ee-981c-e9d8cc94638b",
"created_at": "2026-11-05T16:05:49.594752Z",
"company_name": "Dren Bio",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/69127740",
"event_type": "funding",
"funding_amount": 350000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Biotechnology company Dren Bio has raised $350M in an oversubscribed private financing round, co-led by Juvia Group and Lightspeed Venture Partners, to advance its antibody-based therapies for cancer and autoimmune diseases.*"
}